G. Sánchez et al. / Inorganica Chimica Acta 363 (2010) 1084–1091
1085
2.2.2. Preparation of complexes [Pd(o-Ph2PC6H4CO–NHR)2][ClO4]2
2. Experimental
[R = iPr (5), Ph (6), 4-MeC6H4 (7), 4-FC6H4 (8)]
2.2.2.1. Method A. The new complexes were obtained by treating a
dichloromethane solution of the corresponding complexes (1–4)
(100 mg, 20 mL) with stoichiometric amount of 1.16 M HClO4
aqueous solution (molar ratio: 1:2). After 1 h stirring at room tem-
perature, the mixture was concentrated to half volume under re-
duced pressure. Addition of diethyl ether caused precipitation of
the new yellow complexes (5–8), which were filtered off, washed
with ether, air dried and recrystallized from CH2Cl2/ether.
2.1. Methods and materials
C, H and N analyses were carried out with a Carlo Erba instru-
ment. IR spectra were recorded on a Perkin–Elmer spectrophotom-
eter 16F PC FT–IR, using Nujol mulls between polyethylene sheets.
NMR data (1H, 31P) were recorded on Bruker Avance 200 and 300
spectrometers. Mass spectrometric analyses were performed on a
Fisons VG Autospec double-focusing spectrometer, operated in po-
sitive mode. Ions were produced by fast atom bombardment (FAB)
with a beam of 25 KeV Cs atoms. The mass spectrometer was oper-
ated with an accelerating voltage of 8 kV and a resolution of at
least 1000. All the solvents were dried by conventional methods.
Pd(dba)2 [35], the diphenylphosphinobenzamide o-Ph2P–C6H4–
CO–NH–R (R = iPr, Ph, 4-MeC6H4 or 4-FC6H4 and iminophosphine
ligands o-Ph2PC6H4CH@N-R (R = iPr or Ph) were prepared by re-
ported procedures [20,21].
2.2.2.2. Method B. To
a solution of [PdCl2(PhCN)2] (100 mg,
0,26 mmol) in 10 mL of dichloromethane, the stoichiometric
amount of the corresponding 2-diphenylphosphinebenzamide
(0.52 mmol, molar ratio 1:2) and AgClO4 (108 mg, 0.52 mmol)
were added. The precipitation of AgCl started immediately. After
30 min of stirring at room temperature the precipitate was re-
moved, and the resulting clear solution was evaporated to half vol-
ume. A yellow precipitate formed after addition of diethyl ether
and then it was filtered off and washed with ether. The complexes
(5–8) were recrystallised from CH2Cl2/ether.
2.2. Synthesis
[Pd(o-Ph2PC6H4CO–NH–iPr)2][ClO4]2 (5): (73% yield).. Mp =
235 °C. Anal. Calc. for C44H44Cl2N2O10P2Pd: C, 52.8; H, 4.4; N, 2.8.
2.2.1. Preparation of complexes [Pd(o-Ph2PC6H4CO–NR)2] [R = iPr (1),
Ph (2), 4-MeC6H4 (3), 4-FC6H4 (4)]
Found: C, 53.1; H, 4.6; N, 2.7.%. FT–IR (nujol, cmꢀ1):
m
(NH) 3287,
(ClO4) 1093 (vs). 1H NMR (300 MHz, CDCl3): d
To a red solution of [Pd(dba)2] (200 mg, 0,35 mmol) in 20 mL of
dicholoromethane was added the stoichiometric amount of the
corresponding 2-diphenylphosphinebenzamide (0.70 mmol, molar
ratio 1:2). The reaction was stirred at room temperature for 24 h
and then it was evaporated to half volume under reduced pressure.
Addition of diethyl ether caused precipitation of the new yellow
complexes, which were filtered off, air dried and recrystallised
from CH2Cl2/ether. The same results were obtained when the reac-
tions were performed under air or N2 atmosphere.
m(CO) 1584 (vs), m
(ppm): 8.89 (m, 2H, NH), 8.30 (m, 2H, P–C6H4–C), 7.92 (m. 2H, P–
C6H4–C), 7.65–7.51 (m, 10H, 2H P–C6H4–C + 8H PPh2), 7.40–7.28
(m, 12H, PPh2), 6.90 (m, 2H, P–C6H4–C), 3.95 (m, 2H, CH-iPr),
0.94 (d, JHH = 6.0 Hz, 12H, CH3-iPr). 31P NMR (300 MHz, CDCl3): d
(ppm) 44.5(s). FAB-MS (positive mode) m/z: 898 (M+-ClO4), 797
(M+-2ClO4).
[Pd(o-Ph2PC6H4CO–NH–Ph)2][ClO4]2
Mp = 194 °C. Anal. Calc. for C50H40Cl2N2O10P2Pd: C, 56.2; H, 3.8;
N, 2.6. Found: C, 56.1; H, 4.0; N, 2.8.%. FT–IR (nujol, cmꢀ1):
(CO)
1578 (vs),
(ClO4) 1097 (vs). 1H NMR (200 MHz, CDCl3): d (ppm):
(6):
(68%
yield).
[Pd(o-Ph2PC6H4CO–N–iPr)2] (1): (72% yield). Mp = 155 °C. Anal.
Calc. for C44H42N2O2P2Pd: C, 66.1; H, 5.3; N, 3.5. Found: C, 65.8;
m
m
H, 5.7; N, 3.6.%. FT–IR (nujol, cmꢀ1): (CO) 1623 (s), 1574 (vs). 1H
m
10.49 (br, 2H, NH), 8.41 (m, 2H, P–C6H4–C), 7.83 (m, 2H, P–C6H4–
C), 7.69–7.16 (m, 32H, 20H PPh2 + 10H N-Ph + 2H P–C6H4–CO–),
6.95 (m, 2H, P–C6H4–C). 31P NMR (300 MHz, CDCl3): d (ppm) 43.2
(s). FAB-MS (positive mode) m/z: 867 (M+-2ClO4 + 1).
NMR (200 MHz, CDCl3): d (ppm): 8.26 (m, 2H, P-C6H4-CO–),
7.88–7.24 (m, 24H, 20H PPh2 + 4H P–C6H4–CO–), 6.43 (m, 2H, P-
C6H4-CO–), 3.70 (m, 2H, CH-iPr), 1.05 (d, JHH = 6.0 Hz, 6H, CH3-iPr),
0.65 (d, JHH = 6.0 Hz, 6H, CH3-iPr). 31P NMR (300 MHz, CDCl3): d
(ppm): 32.5 (s). FAB-MS (positive mode) m/z: 799 (M++1).
[Pd(o-Ph2PC6H4CO–NH–C6H4–4Me)2][ClO4]2 (7) (69% yield).
Mp = 231 °C. Anal. Calc. for C52H44Cl2N2O10P2Pd: C, 57.0; H, 4.1;
N, 2.6. Found: C, 57.2; H, 4.3; N, 2.9.%. FT–IR (nujol, cmꢀ1):
3371 (s), m(CO) 1577 (vs), m
m
(NH)
[Pd(o-Ph2PC6H4CO–N–Ph)2] (2) (80% yield). Mp = 177 °C. Anal.
Calc. for C50H38N2O2P2Pd: C, 69.3; H, 4.4; N, 3.2. Found: C, 69.4;
(ClO4) 1103 (vs). 1H NMR (300 MHz,
H, 4.7; N, 3.3.%. FT–IR (nujol, cmꢀ1): (CO) 1655 (s), 1580 (vs). 1H
m
CDCl3): d (ppm): 10.51 (s, 2H, NH), 8.46 (m, 2H, P–C6H4–C), 7.88
(m, 2H, P–C6H4–C), 7.55–7.48 (m, 6H, 2H P–C6H4–C + 4H N–
C6H4–CH3), 7.36–7.28 (m, 20 H PPh2) 7.05 (m, 4H, N–C6H4–Me),
6.94 (m, 2H, P–C6H4–C), 2.27 (s, 6H, CH3). 31P NMR (300 MHz,
CDCl3): d (ppm) 43.3 (s). FAB-MS (positive mode) m/z: 995 (M+-
ClO4), 894 (M+-2ClO4).
NMR (200 MHz, CDCl3): d (ppm): 8.11 (m, 2H, P–C6H4–CO–),
7.92–7.31 (m, 32H, 20H PPh2 + 10H N-Ph + 2H P–C6H4–CO–),
6.58 (m, 2H, P–C6H4–CO–). 31P NMR (300 MHz, CDCl3): d (ppm)
33.3 (s). FAB-MS (positive mode) m/z: 867 (M+ + 1).
[Pd(o-Ph2PC6H4CO–N–C6H4–4Me)2]
Mp = 196 °C. Anal. Calc. for C52H42N2O2P2Pd: C, 69.8; H, 4.7; N,
3.1 Found: C, 69.5; H, 5.1; N, 3.3.%. FT–IR (nujol, cmꢀ1):
(CO)
(3)
(74%
yield).
[Pd(o-Ph2PC6H4CO–NH–C6H4–4F)2][ClO4]2 (8) (75% yield).
m
Mp = 191 °C. Anal. Calc. for C50H38Cl2F2N2O10P2Pd: C, 54.4; H, 3.5;
1612 (s), 1593 (vs). 1H NMR (300 MHz, CDCl3): d (ppm) 7.97 (m,
2H, P–C6H4–CO–), 7.52–7.35 (m, 12H, 8H PPh2 + 4H N–C6H4–
CH3), 7.22 (m, 2H, P–C6H4–CO–), 7.09 (m, 2H, P–C6H4–CO–), 6.86
(m, 12H, PPh2), 6.68 (m, 4H, N–C6H4–CH3), 6.57 (m, 2H, P–C6H4–
CO–), 2.16 (s, 6H, CH3). 31P NMR (300 MHz, CDCl3): d (ppm) 33.2
(s). FAB-MS (positive mode) m/z: 894 (M+).
N, 2.5. Found: C, 54.7; H, 3.9; N, 2.8.%. FT–IR (nujol, cmꢀ1):
3336 (s), m(CO) 1580 (vs), m
m
(NH)
(ClO4) 1100 (vs). 1H NMR (200 MHz,
CDCl3): d (ppm): 11.05 (br, 2H, NH), 8.46 (m, 2H, P–C6H4–C), 7.85
(m, 2H, P–C6H4–C), 7.75 (m, 2H, P–C6H4–C), 7.69–7.62 (m, 16H,
12H PPh2 + 4H N–C6H4–F), 7.40–7.30 (m, 10H, 8H aromatics +2H
P–C6H4–C), 6.99 (m, 4H N–C6H4–F). 31P NMR (300 MHz, CDCl3): d
(ppm) 41.4 (s). 19F NMR (200 MHz, CDCl3): d (ppm): ꢀ120.3(s).
FAB-MS (positive mode) m/z: 903 (M+-2ClO4).
[Pd(o-Ph2PC6H4CO–N–C6H4–4F)2] (4) (68% yield). Mp = 206 °C.
Anal. Calc. for C50H36F2N2O2P2Pd: C, 66.5; H, 4.0; N, 3.1. Found: C,
66.4; H, 4.4; N, 3.4.%. FT–IR (nujol, cmꢀ1):
m(CO) 1604(s), 1576
(vs). 1H NMR (200 MHz, CDCl3): d (ppm) 8.02 (m, 2H, P–C6H4–
CO–), 7.52–7.35 (m, 12H, 8H PPh2 + 4H N–C6H4–F), 7.22 (m, 2H,
P–C6H4–CO–), 7.19 (m, 2H, P–C6H4–CO–), 6.90 (m, 12H, PPh2),
6.58 (m, 6H, 4H N–C6H4–F + 2H P–C6H4–CO–). 31P NMR
(300 MHz, CDCl3): d (ppm) 33.5 (s). 19F NMR (200 MHz, CDCl3): d
(ppm): ꢀ120.3 (s). FAB-MS (positive mode) m/z: 902 (M+).
2.2.3. Preparation of complexes [Pd(o-Ph2PC6H4CH@N-R)2] [ClO4]2
[R = iPr (9), Ph (10)]
To a solution of [PdCl2(PhCN)2] (100 mg, 0,26 mmol) in 10 mL of
dichloromethane, the stoichiometric amount of the corresponding
iminophosphine (0.52 mmol, CH2Cl2 solution) and AgClO4 (108 mg,
0.52 mmol) were added. The precipitation of AgCl started immedi-